The Kingdom of Saudi Arabia has made a medical breakthrough, with King Abdulaziz Medical City in Riyadh (KAMC-RD) of the Ministry of National Guard - Health Affairs (MNGHA) successfully utilizing Casgevy gene therapy through CRISPR gene editing technology to treat a 13-year-old patient with thalassemia major. The achievement is the first of its kind outside clinical trials and research, the Saudi Press Agency reported on Thursday. The patient, who had been reliant on blood transfusions every three weeks since birth, left the medical city after the successful transplantation of gene cells, making a complete recovery, according to the SPA report. The Kingdom is preparing to soon implement more of these advanced gene therapies for several patients with sickle cell anemia and thalassemia, further solidifying its position in the field of gene therapy on a global scale. Source: Kuwait News Agency
Related Articles
Dozens Martyred, Injured in New Israeli Airstrike on Jabalia camp
Gaza, Dozens of Palestinians were martyred and others were injured as a result of a violent Israeli bombardment that targeted a residential square in the Al Faluga area in the Jabalia refugee camp, northern Gaza Strip, in what appears to be a new massa…
Cholera outbreak claims 43 more lives in South Africa
A cholera outbreak in South Africa has killed 43 more people while 197 others were infected, the health ministry said on Monday, urging the public to stick to health precautions to keep the waterborne disease at bay.While the infection rate has slowed …
Kuwait hlt ministry kick starts annual chronic conditions awareness campaign
The Health Ministry said on Thursday that its annual campaign to spread awareness on chronic conditions began as part of its sustainable development program to combat disease and illness.
Speaking to the press, Director of Health Performance Departm…